Definium Therapeutics
This role serves as a key technical and strategic leader within the Pharmaceutical Development organization, overseeing outsourced drug product development and manufacturing activities across all development phases and commercial readiness. The Director acts as the primary technical lead for CDMO partners, driving formulation, process development, technology transfer, and validation while ensuring alignment with quality, regulatory, and supply objectives. The position requires deep expertise in drug product manufacturing, secondary packaging development, and cross-functional CMC strategy in a virtual environment.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2019
Definium Therapeutics (formerly MindMed) is a clinical-stage biopharmaceutical company harnessing the therapeutic potential of psychedelic medicine to develop treatments for psychiatric conditions including generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. Its lead programs include DT120 ODT, a proprietary formulation of lysergide (LSD) D-tartrate, and DT402, the R-enantiomer of MDMA targeting core symptoms of autism spectrum disorder. The company is guided by precision science and evidence-based development to redefine mental healthcare.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Definium Therapeutics.
Associate Director, Pharmaceutical Development
Mirum Pharmaceuticals
Director, CMC Product Development – Small Molecule
Beeline Medicines
Associate Director, CMC Product Development – Small Molecule
Beeline
Senior Director, Drug Substance Development
altimmune
CMC Professional
Crescent Biopharma
Principal Scientist I, Biologics Drug Product Development
AbbVie